Early Initiation Rather Than Prolonged Duration of Antiretroviral Therapy in HIV Infection Contributes to the Normalization of CD8 T-Cell Counts

Clinical Infectious Diseases

Volumn 62, Issue 2, 2016, Pages 250-257

  Cao, Wei ^a,b,i   Mehraj, Vikram ^a,b   Trottier, Benoit ^c   Baril, Jean Guy ^d   Leblanc, Roger ^b,e   Lebouche, Bertrand ^b   Cox, Joseph ^b   Tremblay, Cecile ^f,g   Lu, Wei ⁱ   Singer, Joel ^h   Li, Taisheng ⁱ   Routy, Jean Pierre ^a,b   Vezina S ^j   Charest, L ^j   Milne, M ^j   Huchet, E ^j   Lavoie, S ^j   Friedman, J ^j   Duchastel, M ^j   Villielm, F ^j   Cote P ^j   Potter, M ^j   Lessard, B ^j   Charron, M A ^j   Dufresne, S ^j   Turgeon, M E ^j   Rouleau, D ^j   Labrecque, L ^j   Fortin, C ^j   De Pokomandy, A ^j   Hal Gagne V ^j   Munoz, M ^j   Deligne, B ^j   Martel Laferriere V ^j   Gilmore, N ^j   Fletcher, M ^j   Szabo, J ^j   more..

^a MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^b Chronic Viral Illness Service   (Canada)

^c Clinique Medicale l'Actuel   (Canada)

^d Clinique Médicale Quartier Latin   (Canada)

^e Clinique Médicale OPUS   (Canada)

^f CHUM Research Centre   (Canada)

^g UNIVERSITÉ DE MONTRÉAL   (Canada)

^h UNIVERSITY OF BRITISH COLUMBIA   (Canada)

ⁱ PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^j NONE

more..

Author keywords

antiretroviral therapy; CD4 CD8 ratio; CD8 T cell count; HIV; primary infection

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ANTIRETROVIRUS AGENT; VIRUS RNA;

ADULT; ANTIVIRAL THERAPY; ARTICLE; CAUCASIAN; CD4 CD8 RATIO; CD4 LYMPHOCYTE COUNT; CD8+ T LYMPHOCYTE; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; EARLY INTERVENTION; ETHNIC DIFFERENCE; FEMALE; FOLLOW UP; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; INFECTION; LONG TERM CARE; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MEN WHO HAVE SEX WITH MEN; MIXED INFECTION; MULTICENTER STUDY; NONHUMAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; TREATMENT DURATION; VIRUS LOAD; BLOOD; HIV INFECTIONS; IMMUNOLOGY; MIDDLE AGED; PATHOLOGY; SECONDARY PREVENTION; TREATMENT OUTCOME;

ADULT; ANTI-RETROVIRAL AGENTS; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; FOLLOW-UP STUDIES; HIV INFECTIONS; HUMANS; LYMPHOCYTE COUNT; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RNA, VIRAL; SECONDARY PREVENTION; TREATMENT OUTCOME; VIRAL LOAD;

EID: 84960079561     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/civ809     Document Type: Article

References (28)

1. Deeks SG, Tracy R, Douek DC. Systemic effects of inflammation on health during chronic HIV infection. Immunity 2013; 39:633-45.
2. Lempicki RA, Kovacs JA, BaselerMW, et al. Impact of HIV-1 infection and highly active antiretroviral therapy on the kinetics of CD4+ and CD8+ T cell turnover in HIV-infected patients. Proc Natl Acad Sci U S A 2000; 97:13778-83.
3. Hellerstein M, Hanley MB, Cesar D, et al. Directly measured kinetics of circulating T lymphocytes in normal and HIV-1-infected humans. Nat Med 1999; 5:83-9.
4. Bastidas S, Graw F, Smith MZ, Kuster H, Gunthard HF, Oxenius A. CD8+ T cells are activated in an antigen-independent manner in HIV-infected individuals. J Immunol 2014; 192:1732-44.
5. Srinivasula S, Lempicki RA, Adelsberger JW, et al. Differential effects of HIV viral load and CD4 count on proliferation of naive and memory CD4 and CD8 T lymphocytes. Blood 2011; 118:262-70.
6. Peretz Y, He Z, Shi Y, et al. CD160 and PD-1 co-expression on HIV-specific CD8 T cells defines a subset with advanced dysfunction. PLoS Pathog 2012; 8:e1002840.
7. Brenchley JM, Karandikar NJ, Betts MR, et al. Expression of CD57 defines replicative senescence and antigen-induced apoptotic death of CD8+ T cells. Blood 2003; 101:2711-20.
8. Desai S, Landay A. Early immune senescence in HIV disease. Curr HIV/AIDS Rep 2010; 7:4-10.
9. Mercier F, Boulassel MR, Yassine-Diab B, et al. Persistent human immunodeficiency virus-1 antigenaemia affects the expression of interleukin-7R∞ on central and effector memory CD+ and CD8+ T cell subsets. Clin Exp Immunol 2008; 152:72-80.
10. Emu B, Moretto WJ, Hoh R, et al. Composition and function of T cell subpopulations are slow to change despite effective antiretroviral treatment of HIV disease. PLoS One 2014; 9:e85613.
11. Ronsholt FF, Ullum H, Katzenstein TL, Gerstoft J, Ostrowski SR. T-cell subset distribution in HIV-1-infected patients after 12 years of treatment-induced viremic suppression. J Acquir Immune Defic Syndr 2012; 61:270-8.
12. Helleberg M, Kronborg G, Ullum H, Ryder LP, Obel N, Gerstoft J. Course and clinical significance of CD8+ T-cell counts in a large cohort of HIV-infected individuals. J Infect Dis 2015; 211:1726-34.
13. Serrano-Villar S, Sainz T, Lee SA, et al. HIV-infected individuals with low CD4/CD8 ratio despite effective antiretroviral therapy exhibit altered T cell subsets, heightened CD8+ T cell activation, and increased risk of non-AIDS morbidity and mortality. PLoS Pathog 2014; 10:e1004078.
14. Serrano-Villar S, Gutierrez C, Vallejo A, et al. The CD4/CD8 ratio in HIV-infected subjects is independently associated with T-cell activation despite long-term viral suppression. J Infect 2013; 66:57-66.
15. Jenabian MA, El-Far M, Vyboh K, et al. Immunosuppressive tryptophan catabolism and gut mucosal dysfunction following early HIV infection. J Infect Dis 2015; 212:355-66.
16. Catalfamo M, Wilhelm C, Tcheung L, et al. CD4 and CD8 T cell immune activation during chronic HIV infection: roles of homeostasis, HIV, type I IFN, and IL-7. J Immunol 2011; 186:2106-16.
17. Mussini C, Lorenzini P, Cozzi-Lepri A, et al. CD4/CD8 ratio normalisation and non-AIDS-related events in individuals with HIV who achieve viral load suppression with antiretroviral therapy: an observational cohort study. Lancet HIV 2015; 2:e98-106.
18. Strain MC, Little SJ, Daar ES, et al. Effect of treatment, during primary infection, on establishment and clearance of cellular reservoirs of HIV-1. J Infect Dis 2005; 191:1410-8.
19. Jain V, Hartogensis W, Bacchetti P, et al. Antiretroviral therapy initiated within 6 months of HIV infection is associated with lower T-cell activation and smaller HIV reservoir size. J Infect Dis 2013; 208:1202-11.
20. Cao W, Mehraj V, Vyboh K, Li T, Routy JP. Antiretroviral therapy in primary HIV-1 infection: Influences on immune activation and gut mucosal barrier dysfunction. AIDS Rev 2015; Accepted.
21. Utay J, Ananworanich J, Slike B, et al. Inflammation persists despite early initiation of ART in acute HIV infection [abstract 47]. Presented at: 22nd Conference on Retroviruses and Opportunistic Infections; 23-24 February 2015; Seattle, WA.
22. Boulassel MR, Mercier F, Gilmore N, Routy JP. Immunophenotypic patterns of CD8+ T cell subsets expressing CD8∞ and IL-7R∞ in viremic, aviremic and slow progressor HIV-1-infected subjects. Clin Immunol 2007; 124:149-57.
23. Fiebig EW, Wright DJ, Rawal BD, et al. Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection. AIDS 2003; 17:1871-9.
24. Plana M, Garcia F, Gallart T, et al. Immunological benefits of antiretroviral therapy in very early stages of asymptomatic chronic HIV-1 infection. AIDS 2000; 14:1921-33.
25. Lee SA, Sinclair E, Jain V, et al. Low proportions of CD28- CD8+ T cells expressing CD57 can be reversed by early ART initiation and predict mortality in treated HIV infection. J Infect Dis 2014; 210:374-82.
26. Horvath S, Levine AJ. HIV-1 infection accelerates age according to the epigenetic clock. J Infect Dis 2015.
27. Nolz JC, Harty JT. IL-15 regulates memory CD8+ T cell O-glycan synthesis and affects trafficking. J Clin Invest 2014; 124:1013-26.
28. Lu W, Mehraj V, Vyboh K, Cao W, Li T, Routy JP. CD4:CD8 ratio as a frontier marker for clinical outcome, immune dysfunction and viral reservoir size in virologically suppressed HIV-positive patients. J Int AIDS Soc 2015; 18:20052.